Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Sales | 87,992 | 168,796 | 16,142 | 31,408 | 158 |
| Gross Profit | 87,992 | 168,796 | 16,142 | 31,408 | 158 |
| Operating Expenses | 181,151 | 107,605 | 72,079 | 68,404 | 81,901 |
| Operating Income | -93,159 | 61,191 | -55,936 | -36,996 | -81,743 |
| Other Income | 8,608 | 6,958 | 1,488 | 2,618 | 22 |
| Pre-tax Income | -84,551 | 68,149 | -54,448 | -34,378 | -81,721 |
| Income Tax | 2 | 174 | 2 | 2 | -2 |
| Net Income Continuous | -84,553 | 67,975 | -54,451 | -34,380 | -81,718 |
| Net Income | $-84,553 | $67,975 | $-54,451 | $-34,380 | $-81,723 |
| EPS Basic Total Ops | -0.84 | 0.72 | -0.65 | -0.47 | -1.34 |
| EPS Basic Continuous Ops | -0.84 | 0.72 | -0.65 | -0.47 | -1.34 |
| EPS Diluted Total Ops | -0.84 | 0.69 | -0.65 | -0.47 | -1.34 |
| EPS Diluted Continuous Ops | -0.84 | 0.69 | -0.65 | -0.47 | -1.34 |
| EPS Diluted Before Non-Recurring Items | -0.84 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-86,692 | $66,699 | $-50,854 | $-32,349 | $-78,251 |